Sarcoptes infestation crusted scabies ordinary scabies scabicide scabies prevalence scabies treatment

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
09 Jul 2021
Historique:
received: 04 04 2021
revised: 05 07 2021
accepted: 05 07 2021
entrez: 6 8 2021
pubmed: 7 8 2021
medline: 7 8 2021
Statut: epublish

Résumé

Currently, there are three known subtypes of scabies: ordinary, crusted, and bullous. The worldwide prevalence of scabies remains high in the 21st century. To decrease the social, economic, and psychological impact on the enormous population infected, a lot of important work has been completed over the last 20 years concerning the management of scabies. For example, a standardization of guidelines for the treatment of scabies has been completed and programs have been designed for the prevention and treatment in endemic populations, called mass drug administrations. Unfortunately, these only apply to the ordinary form of scabies. Moreover, resistance to the drugs currently used in treatment is growing, which imposes the need to search for new treatments. For this purpose, new acaricides are being developed to enhance the therapeutic options for the patients' benefit and effectively treat this disease. There is also the necessity for prevention before the development of scabies. An effective vaccine has the potential to protect people before this disease, especially in endemic areas. Unfortunately, there are no such vaccines against

Identifiants

pubmed: 34358018
pii: pathogens10070868
doi: 10.3390/pathogens10070868
pmc: PMC8308645
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

PLoS Negl Trop Dis. 2014 May 22;8(5):e2872
pubmed: 24854034
J Paediatr Child Health. 2018 Jun;54(6):625-632
pubmed: 29442387
Parasit Vectors. 2020 Oct 17;13(1):524
pubmed: 33069261
Pediatr Dermatol. 2010 Sep-Oct;27(5):525-6
pubmed: 21182645
Pediatr Rev. 2016 Nov;37(11):e45-e47
pubmed: 27803149
N Engl J Med. 2010 Feb 25;362(8):717-25
pubmed: 20181973
Indian J Dermatol Venereol Leprol. 2005 Jan-Feb;71(1):53-4
pubmed: 16394369
Trans R Soc Trop Med Hyg. 2021 Mar 25;:
pubmed: 33763705
Pediatr Clin North Am. 2009 Dec;56(6):1421-40
pubmed: 19962029
PLoS Negl Trop Dis. 2016 Jun 27;10(6):e0004803
pubmed: 27348119
PLoS One. 2012;7(7):e40489
pubmed: 22792350
J Dermatol. 2003 May;30(5):411-6
pubmed: 12773808
J Am Acad Dermatol. 1991 Feb;24(2 Pt 1):179-81
pubmed: 1706736
Arch Dermatol. 1989 Dec;125(12):1670-1
pubmed: 2480080
Parasite. 2018;25:33
pubmed: 30016258
PLoS Negl Trop Dis. 2016 Oct 12;10(10):e0005030
pubmed: 27732588
Br Med J. 1973 Jun 16;2(5867):666
pubmed: 4714864
Clin Infect Dis. 2019 Mar 5;68(6):927-933
pubmed: 29985978
Pediatr Dermatol. 2012 Jul-Aug;29(4):430-6
pubmed: 22211573
Antimicrob Agents Chemother. 2020 Apr 21;64(5):
pubmed: 32122897
Dermatology. 2019;235(2):79-90
pubmed: 30544123
Br J Dermatol. 1975 Mar;92(3):333-7
pubmed: 807230
Am J Trop Med Hyg. 2016 Feb;94(2):258-266
pubmed: 26787146
J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1248-1253
pubmed: 28639722
Lancet. 2016 Oct 8;388(10053):1545-1602
pubmed: 27733282
Lancet Infect Dis. 2015 Aug;15(8):960-7
pubmed: 26088526
J Am Acad Dermatol. 1984 Aug;11(2 Pt 1):210-5
pubmed: 6434601
Trends Parasitol. 2017 Jun;33(6):463-472
pubmed: 28285851
Epidemiol Infect. 2019 Aug 05;147:e250
pubmed: 31496448
Br J Dermatol. 2020 Nov;183(5):808-820
pubmed: 32034956
J Gen Intern Med. 2012 Feb;27(2):257
pubmed: 21671131
PLoS Negl Trop Dis. 2015 Mar 04;9(3):e0003452
pubmed: 25738499
Br J Dermatol. 2018 Oct;179(4):889-895
pubmed: 29624634
Dermatol Ther. 2020 Jan;33(1):e13186
pubmed: 31830356
Int J Dermatol. 2012 Mar;51(3):275-82
pubmed: 22348561
J Pediatr. 2016 Dec;179:270-270.e1
pubmed: 27671115
Acta Derm Venereol. 2020 Apr 20;100(9):adv00112
pubmed: 32207535
Parasitology. 2014 May;141(6):725-32
pubmed: 24476932
J Dtsch Dermatol Ges. 2016 Nov;14(11):1155-1167
pubmed: 27879074
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
PLoS Negl Trop Dis. 2010 Jul 20;4(7):e756
pubmed: 20668508
Br J Dermatol. 2002 Sep;147(3):603
pubmed: 12207611
J Nippon Med Sch. 2014;81(3):157-63
pubmed: 24998962
J Clin Microbiol. 2017 May;55(5):1233-1236
pubmed: 28442611
Epidemiol Infect. 2016 Aug;144(11):2462-71
pubmed: 27019288
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Parasit Vectors. 2017 Jun 20;10(1):297
pubmed: 28633664
J Clin Pharm Ther. 2017 Dec;42(6):793-799
pubmed: 28948630
J Am Acad Dermatol. 2020 Mar;82(3):533-548
pubmed: 31310840
Parasite Immunol. 2014 Nov;36(11):585-93
pubmed: 25081184
Br Med J. 1941 Sep 20;2(4211):397-401
pubmed: 20783865
Parasit Vectors. 2016 Nov 22;9(1):594
pubmed: 27876081
Clin Exp Dermatol. 2004 May;29(3):315
pubmed: 15115522
Br J Dermatol. 2020 Feb;182(2):498-500
pubmed: 31535362
J Dtsch Dermatol Ges. 2019 Jan;17(1):15-23
pubmed: 30480868
J Am Acad Dermatol. 2003 Aug;49(2):346-50
pubmed: 12894098
Clin Vaccine Immunol. 2010 Sep;17(9):1428-38
pubmed: 20631334
Trends Parasitol. 2019 Nov;35(11):931-943
pubmed: 31474559
PLoS Negl Trop Dis. 2017 Mar 9;11(3):e0005437
pubmed: 28278252
Br J Dermatol. 2019 Apr;180(4):888-893
pubmed: 30376179
Lancet. 1972 Jan 29;1(7744):249-51
pubmed: 4109709
Infez Med. 2019 Sep 1;27(3):332-335
pubmed: 31545779
J Dermatol. 2006 Mar;33(3):196-201
pubmed: 16620226
Ann Dermatol Venereol. 2017 May;144(5):356-361
pubmed: 28063594
Lancet Infect Dis. 2017 Dec;17(12):1220-1221
pubmed: 28941562
PLoS Negl Trop Dis. 2009 Jun 23;3(6):e467
pubmed: 19547749
JAMA. 1974 Nov 11;230(6):878
pubmed: 4138733
Bull World Health Organ. 2005 Jan;83(1):34-42
pubmed: 15682247
PLoS Negl Trop Dis. 2014 Jun 19;8(6):e2928
pubmed: 24945501
J Am Acad Dermatol. 1987 Jul;17(1):136-9
pubmed: 2956293
J Dermatol. 2003 Sep;30(9):694-6
pubmed: 14578561
Cutis. 2017 Mar;99(3):202-204
pubmed: 28398415
Exp Appl Acarol. 2014 Jul;63(3):401-12
pubmed: 24729069
Lancet Infect Dis. 2019 May;19(5):510-518
pubmed: 30956111
Br Med J. 1942 Jul 4;2(4252):1-4
pubmed: 20784310
PLoS Negl Trop Dis. 2013 Aug 08;7(8):e2167
pubmed: 23951369
J Dermatol. 2017 Sep;44(9):991-1014
pubmed: 28561292
Br Med J. 1941 Sep 20;2(4211):405-6
pubmed: 20783868
J Clin Microbiol. 2015 Jul;53(7):2095-102
pubmed: 25903566
Dermatology. 2011;223(2):104-6
pubmed: 21540570
Pediatr Dermatol. 2014 Nov-Dec;31(6):753-4
pubmed: 24138478
Am J Trop Med Hyg. 2016 Sep 7;95(3):689-93
pubmed: 27402514
Lancet. 2006 May 27;367(9524):1767-74
pubmed: 16731272
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
Vaccines (Basel). 2020 Mar 16;8(1):
pubmed: 32187979
Br J Dermatol. 1993 Feb;128(2):217-9
pubmed: 8457457
Am J Trop Med Hyg. 2017 Dec;97(6):1746-1748
pubmed: 29016306
Parasit Vectors. 2018 Nov 20;11(1):599
pubmed: 30454025
J Infect. 2005 Jun;50(5):375-81
pubmed: 15907543
Epidemiol Rev. 1989;11:126-50
pubmed: 2509232
Int J Dermatol. 2018 Nov;57(11):1293-1298
pubmed: 29663338

Auteurs

Katarzyna Talaga-Ćwiertnia (K)

Jagiellonian University Medical College, Faculty of Medicine, Chair of Microbiology, Department of Infection Control and Mycology, 31-008 Kraków, Poland.

Classifications MeSH